Business UpdateMay 6, 2026, 06:14 AM
BioLargo CEO Hosts Town Hall, Details Key Business Updates
AI Summary
BioLargo, Inc. CEO Dennis P. Calvert hosted a town hall session, providing updates on the company's five operating subsidiaries and addressing the perceived market valuation disconnect. Key highlights include a new strategic relationship with Aquatech for PFAS solutions, a distribution agreement with Al Hikma for Clyra Medical's wound care products, and a $1.2 million contract for the engineering group's mineral extraction project. Calvert emphasized significant operational milestones and ongoing efforts to secure funding and partnerships for its pre-commercial battery technology.
Key Highlights
- CEO Dennis P. Calvert hosted a shareholder town hall on Discord on May 5, 2026.
- BioLargo's market cap is ~$50M, with Clyra Medical's stake valued at ~$50M.
- Announced strategic relationship with Aquatech for PFAS water treatment solutions.
- Clyra Medical signed a distribution agreement with Al Hikma for 500M+ population.
- Engineering group secured a $1.2M contract for mineral extraction design phase.
- First municipal AEC (PFAS) installation went live in Lake Stockholm in January.
- Cellinity (sodium battery) is in active discussions for major capital funding, including government sources.
- Company reported $3.8M cash at end of 2025, plus $1.7M raised for Clyra.